Introduction: Current evidence indicates that the impact of GeneXpert for diagnosing TB in low- and middle-income countries (LMICs) has not demonstrated equivalent outcomes when compared to Xpert evaluations in upper-middle-income countries. Challenges associated with implementation are possible contributing factors preventing this innovative diagnostic technology from achieving more significant public health outcomes. This review aimed to assess the use of implementation science frameworks when reporting the enablers and barriers for the implementation of GeneXpert for diagnosing TB in LMICs. Methods: We conducted a qualitative systematic review of the peer-reviewed literature using PubMed, Medline, and Scopus. Eligible articles were ...
Several interventions for tuberculosis (TB) control have been recommended by the World Health Organi...
<div><p>Background</p><p>India has announced a goal of universal access to quality tuberculosis (TB)...
Background: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limite...
While previous research has provided evidence of the diagnostic accuracy of the GeneXpert MTB/RIF (G...
Nucleic acid amplification tests such as Xpert MTB/RIF (Xpert) have the potential to revolutionize t...
Background: Early access to diagnosis is crucial for effective management of any disease including t...
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide with an estimated 9.0...
Thesis (Master's)--University of Washington, 2016-06Introduction: Mozambique ranks as one of the 22 ...
Background Early access to diagnosis is crucial for effective management of any disease including tu...
In countries with a low incidence of multidrug-resistant tuberculosis (MDR-TB), universal testing wi...
The GeneXpert MTB/RIF assay (Xpert) is a novel automated diagnostic tool for tuberculosis but its op...
BackgroundDelays in diagnosis and treatment of tuberculosis (TB) remain common in high-burden countr...
BackgroundGeneXpert is an effective and rapid molecular system used for tuberculosis (TB) diagnosis....
BackgroundNewer molecular testing platforms are now available for deployment at lower-level communit...
Background and challenges to implementation: Nation- al TB Prevalence Surveys (TBPS) provide valuabl...
Several interventions for tuberculosis (TB) control have been recommended by the World Health Organi...
<div><p>Background</p><p>India has announced a goal of universal access to quality tuberculosis (TB)...
Background: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limite...
While previous research has provided evidence of the diagnostic accuracy of the GeneXpert MTB/RIF (G...
Nucleic acid amplification tests such as Xpert MTB/RIF (Xpert) have the potential to revolutionize t...
Background: Early access to diagnosis is crucial for effective management of any disease including t...
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide with an estimated 9.0...
Thesis (Master's)--University of Washington, 2016-06Introduction: Mozambique ranks as one of the 22 ...
Background Early access to diagnosis is crucial for effective management of any disease including tu...
In countries with a low incidence of multidrug-resistant tuberculosis (MDR-TB), universal testing wi...
The GeneXpert MTB/RIF assay (Xpert) is a novel automated diagnostic tool for tuberculosis but its op...
BackgroundDelays in diagnosis and treatment of tuberculosis (TB) remain common in high-burden countr...
BackgroundGeneXpert is an effective and rapid molecular system used for tuberculosis (TB) diagnosis....
BackgroundNewer molecular testing platforms are now available for deployment at lower-level communit...
Background and challenges to implementation: Nation- al TB Prevalence Surveys (TBPS) provide valuabl...
Several interventions for tuberculosis (TB) control have been recommended by the World Health Organi...
<div><p>Background</p><p>India has announced a goal of universal access to quality tuberculosis (TB)...
Background: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limite...